Zerion Pharma is a non-listed Danish company seeking €2-3m in a private placement round.
Management will briefly run through the investment proposal and business case. Then management will focus on the regulatory environment governing the Dispersome™ technology, formulation of new drugs, and reformulation of existing drugs.
Last but not least CEO Ole Wiborg will give a little flavor on the company’s strategic partnerships.
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Meet Zerion Pharma’s management and regulatory team – CEO Ole Wiborg, CFO Jakob Dynnes Hansen, and Mónica González VP Regulatory Affairs. Management will briefly run through the investment proposal and business case. Then management will focus on the regulatory environment governing the Dispersome™ technology, formulation of new drugs, and reformulation of existing drugs. Last but not least CEO Ole Wiborg will give a little flavor on the company’s strategic partnerships.
Listen to Zerion Pharma’s management team – CEO Ole Wiborg and CFO Jakob Dynnes Hansen introducing the company in relation to a private placement of 2-3 mio. EUR.
Zerion Pharma is a non-listed Danish company.